IRIS
ORSO, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 537
NA - Nord America 214
AS - Asia 178
SA - Sud America 1
Totale 930
Salva come PNG Salva come JPEG
Nazione #
IE - Irlanda 279
US - Stati Uniti d'America 213
IT - Italia 113
SG - Singapore 85
DE - Germania 83
HK - Hong Kong 64
SE - Svezia 31
VN - Vietnam 18
FI - Finlandia 12
CN - Cina 10
UA - Ucraina 9
NL - Olanda 6
CZ - Repubblica Ceca 2
BE - Belgio 1
CA - Canada 1
CL - Cile 1
GB - Regno Unito 1
IN - India 1
Totale 930
Salva come PNG Salva come JPEG
Città #
Dublin 279
Hong Kong 64
Singapore 63
Mülheim 49
Jacksonville 17
Dong Ket 16
Turin 15
Milan 12
Bremen 11
Dearborn 10
Santa Clara 10
Helsinki 8
Piemonte 8
Boardman 7
Amsterdam 6
New York 5
Novara 5
Lawrence 4
Munich 4
Princeton 4
Ashburn 3
Beijing 3
San Mauro Torinese 3
Wilmington 3
Andover 2
Berlin 2
Brno 2
Francavilla al Mare 2
Hanoi 2
Naples 2
Rapallo 2
San Giorgio di Nogaro 2
San Mateo 2
Trecate 2
Ann Arbor 1
Bangalore 1
Chengdu 1
Dreieich 1
Hefei 1
Jena 1
Lappeenranta 1
Louvain 1
Monmouth Junction 1
Nanchang 1
Noicattaro 1
Norwalk 1
Rome 1
Shanghai 1
Termini Imerese 1
Toronto 1
Totale 645
Salva come PNG Salva come JPEG
Nome #
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 74
Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes 57
TCR gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naïve and memory T-cells without prior stimulation of endogenous TCR 47
microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression 27
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma 24
Stroma-derived miR-214 coordinates tumor dissemination 24
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 21
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 21
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition 21
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion 21
Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer 20
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 20
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 19
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 18
Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity 18
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC 17
Formation of STAT5/PPAR{gamma} Transcriptional Complex Modulates Angiogenic Cell Bioavailability in Diabetes 17
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 17
Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region 17
AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase 17
miR-21 coordinates tumor growth and modulates KRIT1 levels 17
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 17
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation 16
miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation 15
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 15
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 15
Role of miRNAs in tumor and endothelial cell interactions during tumor progression 15
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 14
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 14
MiR-146a exerts differential effects on melanoma growth and metastatization 14
microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 13
Interference with Activator Protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation- sensitivity in breast cancer cells 13
MicroRNAs in metabolism for precision treatment of lung cancer 13
miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions 13
A computational pipeline to identify new potential regulatory motifs in melanoma progression. 12
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions 12
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies 11
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 11
Do predicted microRNAs control gene networks involved in breast cancer progression? 11
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 11
Analysis of the regulatory regions of AP-2alpha-modulated genes selected for oral presentation and winner of the "Premio Chiara D'Onofrio Giovani Riercatori 2009" 11
miR-148b is a major coordinator in a Relapse-associated miR signature in Breast Tumors 11
Do predicted microRNAs control gene networks involved in breast cancer progression? 11
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1 10
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 9
Emerging roles of 3D-culture systems in tackling tumor drug resistance 9
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 9
The AP-2alpha and AP-2gamma transcription factors regulate tumor formation 9
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 9
Identification and characterization of microRNAs involved in tumor progression and metastasis 9
ACTIVATOR PROTEIN-2 ALPHA TRANSCRIPTION FACTOR ROLES IN NEURONS 9
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells 8
POSSIBLE OESTROGENIC EFFECTS ON AP-2 ALPHA EXPRESSION AND AP-2 ALPHA POTENTIAL ROLE IN nNOS REGULATION IN MOUSE HYPOTHALAMUS 8
microRNA and cancer progression in Breast Tumours 8
CyTRANSFINDER: A Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction 7
DIFFERENTIAL REGULATION OF AP-2 GENES BY ESTROGEN IN HUMAN BREAST CANCER CELLS 7
High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma 7
The AP-2alpha and AP-2gamma transcription factors regulate tumor progression and cell movement via specific genetic programs 7
Co-localization of AP2alpha transcription factor and TH-immunoreactive neurons in mouse locus coeruleus 7
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 6
The Ap-Alpha transcription factor regulates tumor cell migration 6
Investigating the epi-miRNome: Identification of epi-miRNAs using transfection experiments 6
DIFFERENTIAL REGULATION OF AP-2 TRANSCRIPTION FACTOR GENE EXPRESSION BY ESTROGEN IN HUMAN BREAST CANCER CELLS 6
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 6
Identification of new AP-2alpha regulated genes: a biological and bioinformatic approach 5
Totale 989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.968
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 6 6 7 2 4 1 3 1
2020/202138 3 0 3 4 3 0 3 0 3 0 3 16
2021/202220 0 2 0 4 1 0 2 0 3 1 1 6
2022/2023426 6 2 2 1 11 24 3 31 249 36 58 3
2023/2024284 17 18 40 17 61 3 42 7 3 2 25 49
2024/2025161 18 3 131 6 3 0 0 0 0 0 0 0
Totale 989